Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine‐1‐phosphate receptor modulator

AIMS: Fingolimod is a sphingosine‐1‐phosphate (S1P) receptor modulator approved for the treatment of the relapsing form of multiple sclerosis (MS). It prevents the egress of lymphocyte subpopulations from lymphoid tissues into the circulation. Here, we explored the broad effects of fingolimod on gen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:CNS Neurosci Ther
Autores principales: Angerer, Ines C., Hecker, Michael, Koczan, Dirk, Roch, Luisa, Friess, Jörg, Rüge, Annelen, Fitzner, Brit, Boxberger, Nina, Schröder, Ina, Flechtner, Kristin, Thiesen, Hans‐Jürgen, Winkelmann, Alexander, Meister, Stefanie, Zettl, Uwe K.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490155/
https://ncbi.nlm.nih.gov/pubmed/29314605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12793
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares